Skip to main content

Advertisement

Table 5 Tumor characteristics, dog responses, and survival for patients in Series II

From: Cancer odor in the blood of ovarian cancer patients: a retrospective study of detection by dogs during treatment, 3 and 6 months afterward

No Test samples 3 m/6 m Diagnosis date Stage Histopathology Grade 3 months* Lotti Hanna 6 months* Lotti Hanna Case record Jan 2013
1 4842/5095 Feb 2009 III/C Seropapillary 2 O O X # Alive/relapse-free
2 3932/4799 June 2008 III/C Seropapillary 3 O X X X Alive/relapse-free
3 406/1018 Nov 2005 III/C Adenocarcinoma 3 X X # X Relapse 2008/Died 2009
4 9807/108 Jan 2005 II/C Adenocarcinoma 2 O X O # Alive/relapse-free
5 8647/8955 Dec 2003 III/C Clear cell 2 X X O X alive/relapse-free
6 10704/1328 Dec 2005 II/C Seropapillary 3 # O O # Alive/relapse-free
7 451/1065 Sept 2005 III/C Undifferentiated 4 X X O # Relapse 2009/alive
8 3835/6750 Feb 2000 III/C Seropapillary 3 X X X X Relapse 2002/died 2005
9 6132/7872 Jan 2004 II/C Seropapillary 2 X X X X Relapse 2006/alive
10 4926/5214 Aug 2008 II/B Seropapillary 2 O # X X Alive/relapse-free
  1. * = all CA-125 values were <35UI.
  2. Dog responses:
  3. X = positive indication as cancer; O = no indication; # = uncertain indication.